Truxima 10 mg/mL
rituximab-abbs · INJECTION, SOLUTION · Cephalon, Inc.
No Recall History
Plain English
Truxima is a injection, solution containing rituximab-abbs at 10 mg/mL, taken intravenous. Manufactured by Cephalon, Inc..
Key Facts
- Brand Name
- Truxima
- Generic Name
- rituximab-abbs
- NDC Code (Product)
63459-104- Manufacturer
- Cephalon, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761088
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 05/04/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Truxima used for?
Truxima contains rituximab-abbs. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Truxima a controlled substance?
Truxima is not classified as a controlled substance by the DEA.
What is the generic name for Truxima?
The generic name for Truxima is rituximab-abbs. There are no other listed brand versions of rituximab-abbs.
What is the NDC code for Truxima 10 mg/mL?
The NDC (National Drug Code) for Truxima 10 mg/mL is 63459-104, listed by Cephalon, Inc..
Other Truxima Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)